{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:12:02Z","timestamp":1792429922875,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interstitial chemotherapy plays a pivotal role in the treatment of glioblastoma multiforme (GBM), an aggressive form of primary brain cancer, by enhancing drug biodistribution to the tumor and avoiding systemic toxicities. The use of new polymer structures that extend the release of cytotoxic agents may therefore increase survival and prevent recurrence. A novel core-sheath fiber loaded with the drug carmustine (BCNU) was evaluated in an <jats:italic>in vivo<\/jats:italic> brain tumor model. Three-dimensional discs were formed from coaxially electrospun fiber membranes and <jats:italic>in vitro<\/jats:italic> BCNU release kinetics were measured. <jats:italic>In vivo<\/jats:italic> survival was assessed following implantation of discs made of compressed core-sheath fibers (NanoMesh) either concurrently with or five days after intracranial implantation of 9L gliosarcoma. Co-implantation of NanoMesh and 9L gliosarcoma resulted in statistically significant long-term survival (&gt;150 days). Empty control NanoMesh confirmed the safety of these novel implants. Similarly, Day 5 studies showed significant median, overall, and long-term survival rates, suggesting optimal control of tumor growth, confirmed with histological and immunohistochemical analyses. Local chemotherapy by means of biodegradable NanoMesh implants is a new treatment paradigm for the treatment for brain tumors. Drug delivery with coaxial core-sheath structures benefits from high drug loading, controlled long-term release kinetics, and slow polymer degradation. This represents a promising evolution for the current treatment of GBM.<\/jats:p>","DOI":"10.1038\/s41598-019-54283-y","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:03:10Z","timestamp":1575025390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Multi-layered core-sheath fiber membranes for controlled drug release in the local treatment of brain tumor"],"prefix":"10.1038","volume":"9","author":[{"given":"Daewoo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umailla","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-4786","authenticated-orcid":false,"given":"Henry","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-6969","authenticated-orcid":false,"given":"Betty","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1868-4442","authenticated-orcid":false,"given":"Andrew J.","family":"Steckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"issue":"6","key":"54283_CR1","doi-asserted-by":"publisher","first-page":"1701024","DOI":"10.1002\/adhm.201701024","volume":"7","author":"Shixuan Chen","year":"2017","unstructured":"Chen, S., Boda, S. K., Batra, S. K., Li, X. & Xie, J. Emerging Roles of Electrospun Nanofibers in Cancer Research. Advanced Healthcare Materials, 1701024, https:\/\/doi.org\/10.1002\/adhm.201701024 (2017).","journal-title":"Advanced Healthcare Materials"},{"key":"54283_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica 131, 803\u2013820, https:\/\/doi.org\/10.1007\/s00401-016-1545-1 (2016).","journal-title":"Acta Neuropathologica"},{"key":"54283_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro, A. & DeAngelis, L. M. Glioblastoma and Other Malignant Gliomas: A Clinical Review. JAMA 310, 1842\u20131850, https:\/\/doi.org\/10.1001\/jama.2013.280319 (2013).","journal-title":"JAMA"},{"key":"54283_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N. Engl. J. Med. 352, 987\u2013996, https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"54283_CR5","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"Richard Daneman","year":"2015","unstructured":"Daneman, R. & Prat, A. The Blood\u2013Brain Barrier. Cold Spring Harbor Perspectives in Biology 7, https:\/\/doi.org\/10.1101\/cshperspect.a020412 (2015).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"54283_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3171\/jns.1994.80.2.0283","volume":"80","author":"H Brem","year":"1994","unstructured":"Brem, H. et al. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Journal of Neurosurgery 80, 283\u2013290, https:\/\/doi.org\/10.3171\/jns.1994.80.2.0283 (1994).","journal-title":"Journal of Neurosurgery"},{"key":"54283_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2008.5.17557","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt, M. J. et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Journal of neurosurgery 110, 583\u2013588, https:\/\/doi.org\/10.3171\/2008.5.17557 (2009).","journal-title":"Journal of neurosurgery"},{"key":"54283_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","volume":"74","author":"H Brem","year":"1991","unstructured":"Brem, H. et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. Journal of Neurosurgery 74, 441\u2013446, https:\/\/doi.org\/10.3171\/jns.1991.74.3.0441 (1991).","journal-title":"Journal of Neurosurgery"},{"key":"54283_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem, H. et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Lancet 345, 1008\u20131012, https:\/\/doi.org\/10.1016\/S0140-6736(95)90755-6 (1995).","journal-title":"The Lancet"},{"key":"54283_CR10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1245\/s10434-010-1081-5","volume":"17","author":"P Menei","year":"2010","unstructured":"Menei, P. et al. Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience. Annals of Surgical Oncology 17, 1740\u20131746, https:\/\/doi.org\/10.1245\/s10434-010-1081-5 (2010).","journal-title":"Annals of Surgical Oncology"},{"key":"54283_CR11","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1245\/s10434-012-2764-x","volume":"20","author":"J Duntze","year":"2013","unstructured":"Duntze, J. et al. Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases. Annals of Surgical Oncology 20, 2065\u20132072, https:\/\/doi.org\/10.1245\/s10434-012-2764-x (2013).","journal-title":"Annals of Surgical Oncology"},{"key":"54283_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","volume":"122","author":"SA Chowdhary","year":"2015","unstructured":"Chowdhary, S. A., Ryken, T. & Newton, H. B. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. Journal of Neuro-Oncology 122, 367\u2013382, https:\/\/doi.org\/10.1007\/s11060-015-1724-2 (2015).","journal-title":"Journal of Neuro-Oncology"},{"key":"54283_CR13","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1021\/acs.accounts.7b00218","volume":"50","author":"J Xue","year":"2017","unstructured":"Xue, J., Xie, J., Liu, W. & Xia, Y. Electrospun Nanofibers: New Concepts, Materials, and Applications. Accounts of Chemical Research 50, 1976\u20131987, https:\/\/doi.org\/10.1021\/acs.accounts.7b00218 (2017).","journal-title":"Accounts of Chemical Research"},{"key":"54283_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/15583720802022257","volume":"48","author":"AK Moghe","year":"2008","unstructured":"Moghe, A. K. & Gupta, B. S. Co-axial Electrospinning for Nanofiber Structures: Preparation and Applications. Polym. Rev. 48, 353\u2013377 (2008).","journal-title":"Polym. Rev."},{"key":"54283_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s11095-006-9036-z","volume":"23","author":"J Xie","year":"2006","unstructured":"Xie, J. & Wang, C.-H. Electrospun Micro- and Nanofibers for Sustained Delivery of Paclitaxel to Treat C6 Glioma in Vitro. Pharmaceutical Research 23, 1817, https:\/\/doi.org\/10.1007\/s11095-006-9036-z (2006).","journal-title":"Pharmaceutical Research"},{"key":"54283_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jconrel.2006.05.031","volume":"114","author":"X Xu","year":"2006","unstructured":"Xu, X. et al. BCNU-loaded PEG\u2013PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells. Journal of Controlled Release 114, 307\u2013316, https:\/\/doi.org\/10.1016\/j.jconrel.2006.05.031 (2006).","journal-title":"Journal of Controlled Release"},{"key":"54283_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jbm.a.32543","volume":"90A","author":"H-H Huang","year":"2009","unstructured":"Huang, H.-H., He, C.-L., Wang, H.-S. & Mo, X.-M. Preparation of core-shell biodegradable microfibers for long-term drug delivery. Journal of Biomedical Materials Research Part A 90A, 1243\u20131251 (2009).","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"54283_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1517\/17425247.2013.758102","volume":"10","author":"Y-Y Tseng","year":"2013","unstructured":"Tseng, Y.-Y., Liao, J.-Y., Chen, W.-A., Kao, Y.-C. & Liu, S.-J. Sustainable release of carmustine from biodegradable poly[(d,l)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies. Expert Opinion on Drug Delivery 10, 879\u2013888, https:\/\/doi.org\/10.1517\/17425247.2013.758102 (2013).","journal-title":"Expert Opinion on Drug Delivery"},{"key":"54283_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1166\/jbn.2017.2353","volume":"13","author":"S Iqbal","year":"2017","unstructured":"Iqbal, S., Rashid, M. H., Arbab, A. S. & Khan, M. Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy. Journal of Biomedical Nanotechnology 13, 355\u2013366, https:\/\/doi.org\/10.1166\/jbn.2017.2353 (2017).","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"54283_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","volume":"94","author":"RF Barth","year":"2009","unstructured":"Barth, R. F. & Kaur, B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology 94, 299\u2013312, https:\/\/doi.org\/10.1007\/s11060-009-9875-7 (2009).","journal-title":"Journal of Neuro-Oncology"},{"key":"54283_CR21","doi-asserted-by":"publisher","first-page":"1094-DD1006-100","DOI":"10.1557\/PROC-1094-DD06-02","volume":"1094","author":"D Han","year":"2008","unstructured":"Han, D., Boyce, S. T. & Steckl, A. J. Versatile core-sheath biofibers using coaxial electrospinning. Mater. Res. Soc. Symp. Proc. 1094, 1094-DD1006-1002 (2008).","journal-title":"Mater. Res. Soc. Symp. Proc."},{"key":"54283_CR22","doi-asserted-by":"publisher","first-page":"015002","DOI":"10.1088\/1758-5082\/6\/1\/015002","volume":"6","author":"N Wang","year":"2014","unstructured":"Wang, N. et al. Electrospun polyurethane-core and gelatin-shell coaxial fibre coatings for miniature implantable biosensors. Biofabrication 6, 015002, https:\/\/doi.org\/10.1088\/1758-5082\/6\/1\/015002 (2014).","journal-title":"Biofabrication"},{"key":"54283_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/am900664v","volume":"2","author":"D Wu","year":"2010","unstructured":"Wu, D., Han, D. & Steckl, A. J. Immunoassay on free-standing electrospun membranes. ACS Applied Materials and Interfaces 2, 252\u2013258, https:\/\/doi.org\/10.1021\/am900664v (2010).","journal-title":"ACS Applied Materials and Interfaces"},{"key":"54283_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2018.12.048","volume":"295","author":"T Shapira-Furman","year":"2019","unstructured":"Shapira-Furman, T. et al. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. Journal of Controlled Release 295, 93\u2013101, https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.048 (2019).","journal-title":"Journal of Controlled Release"},{"key":"54283_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2017.03.007","volume":"263","author":"C Zhang","year":"2017","unstructured":"Zhang, C. et al. Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats. Journal of Controlled Release 263, 112\u2013119, https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.007 (2017).","journal-title":"Journal of Controlled Release"},{"key":"54283_CR26","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1158\/1078-0432.ccr-18-3850","volume":"3850","author":"SJ Smith","year":"2019","unstructured":"Smith, S. J. et al. Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste. Clinical Cancer Research, clincanres. 3850, 2018, https:\/\/doi.org\/10.1158\/1078-0432.ccr-18-3850 (2019).","journal-title":"Clinical Cancer Research, clincanres."},{"key":"54283_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/nn504905q","volume":"9","author":"A Mangraviti","year":"2015","unstructured":"Mangraviti, A. et al. Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo. ACS Nano 9, 1236\u20131249, https:\/\/doi.org\/10.1021\/nn504905q (2015).","journal-title":"ACS Nano"},{"key":"54283_CR28","doi-asserted-by":"publisher","first-page":"370ra180","DOI":"10.1126\/scitranslmed.aag2942","volume":"8","author":"D Mathios","year":"2016","unstructured":"Mathios, D. et al. Anti\u2013PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. Science Translational Medicine 8, 370ra180\u2013370ra180, https:\/\/doi.org\/10.1126\/scitranslmed.aag2942 (2016).","journal-title":"Science Translational Medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54283-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:37:04Z","timestamp":1671295024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54283-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54283"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54283-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B. receives research funding from NIH, Johns Hopkins University, Arbor Pharmaceuticals, Bristol-Myers Squibb, and Acuity Bio Corp* and philanthropy. H.B. is also a consultant for AsclepiX Therapeutics, StemGen, Accelerating Combination Therapies*, Camden Partners*, LikeMinds, Inc*, Galen Robotics, Inc.* and Nurami Medical* (*includes equity or options).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17936"}}